1. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Issue 6 (June 2017) Authors: Tepper, Stewart; Ashina, Messoud; Reuter, Uwe; Brandes, Jan L; Doležil, David; Silberstein, Stephen; Winner, Paul; Leonardi, Dean; Mikol, Daniel; Lenz, Robert Journal: Lancet neurology Issue: Volume 16:Issue 6(2017:Jun.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗